HIGHTIDE PRESS RELEASES
The HTD4010 has been registered by the Australian Drug Administration and is about to enter Phase I clinical trials in Australia. Clinical data will be...
July 22, 2015
We will contact you as soon as possible
© 2020 HighTide Therapeutics Inc.